Are acinic cell carcinomas of the breast and salivary glands distinct diseases?

Histopathology

Volumn 67, Issue 4, 2015, Pages 529-537

  Piscuoglio, Salvatore ^a   Hodi, Zsolt ^b   Katabi, Nora ^a   Guerini Rocco, Elena ^a,c   Macedo, Gabriel S ^a   Ng, Charlotte K Y ^a   Edelweiss, Marcia ^a   De Mattos Arruda, Leticia ^a,d   Wen, Hannah Y ^a   Rakha, Emad A ^b   Ellis, Ian O ^b   Rubin, Brian P ^e   Weigelt, Britta ^a   Reis Filho, Jorge S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Breast; PIK3CA; Salivary gland; Sequencing; TP53

Indexed keywords

ACINAR CELL CARCINOMA; ACINIC CELL CARCINOMA OF THE BREAST; ACINIC CELL CARCINOMA OF THE SALIVARY GLAND; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE; PIK3CA GENE; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; SOMATIC MUTATION; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE; DNA MUTATIONAL ANALYSIS; GENETICS; MICRODISSECTION; MIDDLE AGED; MUTATION; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND TUMOR; YOUNG ADULT;

PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; PROTEIN P53;

ADULT; AGED; CARCINOMA, ACINAR CELL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRODISSECTION; MIDDLE AGED; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84941599966     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12673     Document Type: Article

References (51)

1. Pia-Foschini M, Reis-Filho JS, Eusebi V, Lakhani SR. Salivary gland-like tumours of the breast: surgical and molecular pathology. J. Clin. Pathol. 2003; 56; 497-506.
2. Foschini MP, Krausz T. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including 'triple negative carcinomas' of low malignant potential. Semin. Diagn. Pathol. 2010; 27; 77-90.
3. Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc. Natl Acad. Sci. USA 2009; 106; 18740-18744.
4. Wetterskog D, Lopez-Garcia MA, Lambros MB et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J. Pathol. 2012; 226; 84-96.
5. Tognon C, Knezevich SR, Huntsman D et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002; 2; 367-376.
6. Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat. Rev. Clin. Oncol. 2009; 6; 718-730.
7. Weigelt B, Geyer FC, Reis-Filho JS. Histological types of breast cancer: how special are they? Mol. Oncol. 2010; 4; 192-208.
8. Marchio C, Weigelt B, Reis-Filho JS. Adenoid cystic carcinomas of the breast and salivary glands (or 'the strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). J. Clin. Pathol. 2010; 63; 220-228.
9. Connor A, Perez-Ordonez B, Shago M, Skalova A, Weinreb I. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by fish: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am. J. Surg. Pathol. 2012; 36; 27-34.
10. Skalova A, Vanecek T, Sima R et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am. J. Surg. Pathol. 2010; 34; 599-608.
11. Chiosea SI, Griffith C, Assaad A, Seethala RR. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am. J. Surg. Pathol. 2012; 36; 343-350.
12. Roncaroli F, Lamovec J, Zidar A, Eusebi V. Acinic cell-like carcinoma of the breast. Virchows Arch. 1996; 429; 69-74.
13. Sakuma T, Mimura A, Tanigawa N, Takamizu R. Fine needle aspiration cytology of acinic cell carcinoma of the breast. Cytopathology 2013; 24; 403-405.
14. Damiani S, Pasquinelli G, Lamovec J, Peterse JL, Eusebi V. Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study. Virchows Arch. 2000; 437; 74-81.
15. Schmitt FC, Ribeiro CA, Alvarenga S, Lopes JM. Primary acinic cell-like carcinoma of the breast - a variant with good prognosis? Histopathology 2000; 36; 286-289.
16. Coyne JD, Dervan PA. Primary acinic cell carcinoma of the breast. J. Clin. Pathol. 2002; 55; 545-547.
17. Elster EA, Markusic J, Ball R et al. Primary acinic cell carcinoma of the breast. Am. Surg. 2002; 68; 993-995.
18. Hirokawa M, Sugihara K, Sai T et al. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma? Histopathology 2002; 40; 223-229.
19. Kahn R, Holtveg H, Nissen F, Holck S. Are acinic cell carcinoma and microglandular carcinoma of the breast related lesions? Histopathology 2003; 42; 195-196.
20. Peintinger F, Leibl S, Reitsamer R, Moinfar F. Primary acinic cell carcinoma of the breast: a case report with long-term follow-up and review of the literature. Histopathology 2004; 45; 645-648.
21. Kinkor Z, Skalova A. Acinic cell-like differentiation in invasive ductal carcinoma and in ductal hyperplasia of the breast - report of two cases. Cesk. Patol. 2005; 41; 29-33.
22. Tanahashi C, Yabuki S, Akamine N, Yatabe Y, Ichihara S. Pure acinic cell carcinoma of the breast in an 80-year-old Japanese woman. Pathol. Int. 2007; 57; 43-46.
23. Reis-Filho JS, Natrajan R, Vatcheva R et al. Is acinic cell carcinoma a variant of secretory carcinoma? A fish study using ETV6 'split apart' probes. Histopathology 2008; 52; 840-846.
24. Huo L, Bell D, Qiu H, Sahin A, Wu Y, Sneige N. Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma. Ann. Diagn. Pathol. 2011; 15; 84-92.
25. Chang ED, Lee EJ, Lee AW, Kim JS, Kang CS. Primary acinic cell carcinoma of the breast: a case report with an immunohistochemical and ultrastructural studies. J. Breast Cancer 2011; 14; 160-164.
26. Zhao Y, Li W, Lang R et al. Primary acinic cell carcinoma of the breast: a case report and review of the literature. Int. J. Surg. Pathol. 2014; 22; 177-181.
27. Shingu K, Ito T, Kaneko G, Itoh N. Primary acinic cell carcinoma of the breast: a clinicopathological and immunohistochemical study. Case Rep. Oncol. Med. 2013; 2013; 372947.
28. Osako T, Takeuchi K, Horii R, Iwase T, Akiyama F. Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis. Histopathology 2013; 63; 509-519.
29. Winkler N, Morrell G, Factor RE. Invasive carcinoma with acinic cell-like features of the breast. Breast J. 2013; 19; 334-335.
30. Ripamonti CB, Colombo M, Mondini P et al. First description of an acinic cell carcinoma of the breast in a brca1 mutation carrier: a case report. BMC Cancer 2013; 13; 46.
31. Falleti J, Coletti G, Rispoli E et al. Acinic cell carcinoma of the breast arising in microglandular adenosis. Case Rep. Pathol. 2013; 2013; 736048.
32. Limite G, Di Micco R, Esposito E et al. The first case of acinic cell carcinoma of the breast within a fibroadenoma: case report. Int. J. Surg. 2014; 12(Suppl 1); S232-S235.
33. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490; 61-70.
34. Banerji S, Cibulskis K, Rangel-Escareno C et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 2012; 486; 405-409.
35. Shah SP, Roth A, Goya R et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012; 486; 395-399.
36. Lakhani SR, International Agency for Research on Cancer, World Health Organization. WHO classification of tumours of the breast. 4th edn. Lyon: IARC Press, 2012.
37. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19; 403-410.
38. Ellis G, Simpson RHW. Acinic cell carcinoma. In Barnes L, Eveson JW, Reichart P, Sidransky D eds. Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005; 216-218.
39. Gomez DR, Katabi N, Zhung J et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 2009; 115; 2128-2137.
40. Marchio C, Iravani M, Natrajan R et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J. Pathol. 2008; 215; 398-410.
41. Natrajan R, Wilkerson PM, Marchiò C et al. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J. Pathol. 2014; 232; 553-565.
42. Piscuoglio S, Ng CK, Martelotto LG et al. Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast. Mol. Oncol. 2014; 8; 1588-1602.
43. Hammond ME, Hayes DF, Dowsett M et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 2010; 28; 2784-2795.
44. Wolff AC, Hammond ME, Hicks DG et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J. Clin. Oncol. 2013; 31; 3997-4013.
45. Weinreb I, Piscuoglio S, Martelotto LG et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat. Genet. 2014; 46; 1166-1169.
46. Cerami E, Gao J, Dogrusoz U et al. The CBIO cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2; 401-404.
47. Wen S, Tsuji T, Li X, Mimura Y, Sasaki K, Shinozaki F. Immunohistochemical detection of p53 protein and proliferating cell nuclear antigen (PCNA) in salivary-gland tumors. Oncol. Rep. 1995; 2; 233-236.
48. Doi R, Kuratate I, Okamoto E, Ryoke K, Ito H. Expression of p53 oncoprotein increases intratumoral microvessel formation in human salivary gland carcinomas. J. Oral Pathol. Med. 1999; 28; 259-263.
49. Skálová A, Sima R, Vanecek T et al. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of tp53 and her-2/neu genes. Am. J. Surg. Pathol. 2009; 33; 1137-1145.
50. Triantafillidou K, Iordanidis F, Psomaderis K, Kalimeras E. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study. J. Oral Maxillofac. Surg. 2010; 68; 2489-2496.
51. Nordkvist A, Röijer E, Bang G et al. Expression and mutation patterns of p53 in benign and malignant salivary gland tumors. Int. J. Oncol. 2000; 16; 477-483.